Entero Therapeutics Statistics
Total Valuation
ENTO has a market cap or net worth of $7.67 million. The enterprise value is $8.77 million.
Important Dates
The next estimated earnings date is Wednesday, November 12, 2025, before market open.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ENTO has 1.59 million shares outstanding. The number of shares has increased by 274.61% in one year.
| Current Share Class | 1.59M |
| Shares Outstanding | 1.59M |
| Shares Change (YoY) | +274.61% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 6.71% |
| Owned by Institutions (%) | 2.59% |
| Float | 1.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.14 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.81, with a Debt / Equity ratio of 0.02.
| Current Ratio | 2.81 |
| Quick Ratio | 0.00 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -84.43 |
Financial Efficiency
Return on equity (ROE) is -24.28% and return on invested capital (ROIC) is -4.47%.
| Return on Equity (ROE) | -24.28% |
| Return on Assets (ROA) | -3.32% |
| Return on Invested Capital (ROIC) | -4.47% |
| Return on Capital Employed (ROCE) | -8.23% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$8.69M |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ENTO has paid $10.60 million in taxes.
| Income Tax | 10.60M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +373.59% in the last 52 weeks. The beta is 0.89, so ENTO's price volatility has been lower than the market average.
| Beta (5Y) | 0.89 |
| 52-Week Price Change | +373.59% |
| 50-Day Moving Average | 1.97 |
| 200-Day Moving Average | 1.60 |
| Relative Strength Index (RSI) | 84.23 |
| Average Volume (20 Days) | 171,440 |
Short Selling Information
The latest short interest is 27,724, so 1.75% of the outstanding shares have been sold short.
| Short Interest | 27,724 |
| Short Previous Month | 253,215 |
| Short % of Shares Out | 1.75% |
| Short % of Float | 1.87% |
| Short Ratio (days to cover) | 0.01 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -4.56M |
| Pretax Income | n/a |
| Net Income | -17.38M |
| EBITDA | -4.58M |
| EBIT | -4.56M |
| Earnings Per Share (EPS) | -$10.85 |
Full Income StatementBalance Sheet
The company has $4,474 in cash and $835,609 in debt, giving a net cash position of -$831,135 or -$0.52 per share.
| Cash & Cash Equivalents | 4,474 |
| Total Debt | 835,609 |
| Net Cash | -831,135 |
| Net Cash Per Share | -$0.52 |
| Equity (Book Value) | 55.38M |
| Book Value Per Share | -3.96 |
| Working Capital | 53.64M |
Full Balance SheetCash Flow
| Operating Cash Flow | -2.89M |
| Capital Expenditures | n/a |
| Free Cash Flow | -2.89M |
| FCF Per Share | -$1.82 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
